Surveillance Practice for MRSA

MRSA has emerged as one of the predominant pathogens in healthcare-associated infections. Treatment options for MRSA are limited and less effective than options available for susceptible S. aureus infections and result in higher morbidity and mortality. Hospitals are debating whether to swab every patient upon admission for Methicillin-Resistant Staphylococcus aureus, or just every patient admitted to the intensive care unit, or just certain patient populations such as those undergoing dialysis or those in pediatric settings. Current estimates suggest that 49-65% of healthcare-associated S. aureus infections reported to NHSN are caused by methicillin- resistant strains.

  • Pathogenesis
  • Epidemiology
  • HHS Prevention Targets

Related Conference of Surveillance Practice for MRSA

May 11-12, 2017

4th International congress on Infectious Diseases

Barcelona, Spain
August 21-23, 2017

3rd Annual Congress on Infectious Diseases

San Francisco, California, USA
September 04-05, 2017

Global Experts Meeting on Sexually Transmitted Diseases

Macau, Hong Kong
September 7-9, 2017

6thEuro-Global Conference on Infectious Diseases

Paris, France
September 13-14, 2017

6th Annual Bacteriology and Parasitology Meeting

Singapore
Sep 25-26, 2017

2nd International Conference on Infection Control

Chicago, Illinois, USA
October 30-November 1, 2017

3rd Annual Congress on Rare Diseases and Orphan Drugs


(10 Plenary Forums - 1 Event)
San Antonio, Texas, USA

Surveillance Practice for MRSA Conference Speakers

Recommended Sessions

Related Journals

Are you interested in